alexa Development Of Oral Mucosal Vaccine Against Multidrug Resistance Shigella Dysenteriae Type- 1 (SD1) | 11148
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Clinical & Cellular Immunology

Priti Desai
ScientificTracks Abstracts: J Clin Cell Immunol
DOI: 10.4172/2155-9899.S1.013
Abstract
Shigellosis is an acute invasive disease of the lower intestine which afflicts millions of people worldwide with an estimated one million fatalities per annum. Among the 50 serotypes and subtypes of Shigella , SD1 is the most virulent type and responsible for epidemics and pandemics. In the last decade, antibiotic resistant SD1 strains have been isolated with increasing frequency in Africa and Asia which reduce the option of effective oral therapy. The magnitude of the public health threat, development of vaccine against Shigella is considered a public health priority. There is no approved Shigella vaccine in the market though attempts have been made to develop an effective vaccine against shigellosis using killed, attenuated and subunit vaccine approach. The purpose of the study is to develop an oral vaccine against SD1 using genetically engineered Lactocoocus lactis expressing SD1 antigens to provide mucosal immunity. L. lactis , being pro-biotic bacteria has been the cynosure of novel vaccine-development platform because of its safety, stability in the stomach, and immunomodulatory properties. In this study, using bioinformatic tools and available literatures, we identified genes OmpA, OspC2 and StxB as a probable vaccine candidates. OmpA and OspC2 were successfully cloned in to L. lactis expression vectors and their presence were confirmed by PCR and RE digestion tests. After confirmation, L. lactis NZ9000 was successfully transformed with the constructed vectors pSEC:OmpA and pSEC:OspC2. Expressed antigens were confirmed by gene specific PCR and Western blotting. The efficacy of these expressed antigens to generate the serum and mucosal specific antibodies in the experimental animals is underway.
Biography
Priti Desai has completed her Ph.D. at the age of 30 years from Bhavnagar University and postdoctoral studies from NIPER-Ahmedabad. She is the Scientist-B in a premier Pharmaceutical Science organization. She has awarded DBT scholarship for post-doctoral studies in NIPER, Ahmedabad. She has independant project on vaccine development against shigellosis which is funded by Central Government Agencies (ICMR). She has a publication in peer reviewd journal like Biotechnology Advances.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7